These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 17420808)
1. Bivalirudin anticoagulation for cardiopulmonary bypass: an unusual case. Nikolaidis N; Velissaris T; Ohri SK Tex Heart Inst J; 2007; 34(1):115-8. PubMed ID: 17420808 [TBL] [Abstract][Full Text] [Related]
2. Cardiopulmonary bypass with bivalirudin in type II heparin-induced thrombocytopenia. Clayton SB; Acsell JR; Crumbley AJ; Uber WE Ann Thorac Surg; 2004 Dec; 78(6):2167-9. PubMed ID: 15561064 [TBL] [Abstract][Full Text] [Related]
3. Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery. Vasquez JC; Vichiendilokkul A; Mahmood S; Baciewicz FA Ann Thorac Surg; 2002 Dec; 74(6):2177-9. PubMed ID: 12643418 [TBL] [Abstract][Full Text] [Related]
4. Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patients with potential heparin-induced thrombocytopenia. Dyke CM; Koster A; Veale JJ; Maier GW; McNiff T; Levy JH Ann Thorac Surg; 2005 Jul; 80(1):299-303. PubMed ID: 15975385 [TBL] [Abstract][Full Text] [Related]
5. Novel techniques in the use of bivalirudin for cardiopulmonary bypass anticoagulation in a child with heparin-induced thrombocytopenia. Dragomer D; Chalfant A; Biniwale R; Reemtsen B; Federman M Perfusion; 2011 Nov; 26(6):516-8. PubMed ID: 21828161 [TBL] [Abstract][Full Text] [Related]
6. Successful use of bivalirudin for combined carotid endarterectomy and coronary revascularization with the use of cardiopulmonary bypass in a patient with an elevated heparin-platelet factor 4 antibody titer. Avery EG; Hilgenberg AD; Cambria RP; Beckerly R; Donnelly AM; Laposata M Anesth Analg; 2009 Apr; 108(4):1113-5. PubMed ID: 19299772 [TBL] [Abstract][Full Text] [Related]
7. Case 1-2006: off-pump coronary artery bypass graft surgery anticoagulation with bivalirudin: a patient with heparin-induced thrombocytopenia syndrome type II and renal failure. Spiess BD; DeAnda A; McCarthy HL; Yeatman D; Katlaps G; Cooper C; Koster A; Aldea GS; Gravlee GP J Cardiothorac Vasc Anesth; 2006 Feb; 20(1):106-11. PubMed ID: 16458228 [No Abstract] [Full Text] [Related]
8. Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin allergy. Pappalardo F; Franco A; Crescenzi G; Poli A; Zangrillo A; Koster A Perfusion; 2007 Jan; 22(1):67-9. PubMed ID: 17633138 [TBL] [Abstract][Full Text] [Related]
9. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study. Dyke CM; Smedira NG; Koster A; Aronson S; McCarthy HL; Kirshner R; Lincoff AM; Spiess BD J Thorac Cardiovasc Surg; 2006 Mar; 131(3):533-9. PubMed ID: 16515902 [TBL] [Abstract][Full Text] [Related]
10. Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery. McNair E; Marcoux JA; Bally C; Gamble J; Thomson D Perfusion; 2016 Apr; 31(3):189-99. PubMed ID: 25934498 [TBL] [Abstract][Full Text] [Related]
11. Bivalirudin Anticoagulation for a Pediatric Patient with Heparin-Induced Thrombocytopenia and Thrombosis Requiring Cardiopulmonary Bypass for Ventricular Assist Device Placement. Faella KH; Whiting D; Fynn-Thompson F; Matte GS J Extra Corpor Technol; 2016 Mar; 48(1):39-42. PubMed ID: 27134308 [TBL] [Abstract][Full Text] [Related]
12. Anticoagulant monitoring techniques in a heparin-induced thrombocytopenia patient undergoing cardiopulmonary bypass using bivalirudin anticoagulant. Baker T; Chan R; Hill F J Extra Corpor Technol; 2004 Dec; 36(4):371-4. PubMed ID: 15679282 [TBL] [Abstract][Full Text] [Related]
13. Routine use of the direct thrombin inhibitor bivalirudin for off-pump coronary artery bypass grafting is safe and effective. Palmer GJ; Sankaran IS; Sparkman GM; Koster A; Dyke CM; Ebra G Heart Surg Forum; 2008; 11(1):E24-9. PubMed ID: 18270134 [TBL] [Abstract][Full Text] [Related]
14. Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial. Koster A; Dyke CM; Aldea G; Smedira NG; McCarthy HL; Aronson S; Hetzer R; Avery E; Spiess B; Lincoff AM Ann Thorac Surg; 2007 Feb; 83(2):572-7. PubMed ID: 17257990 [TBL] [Abstract][Full Text] [Related]
15. Management of protamine allergy with bivalirudin during coronary artery revascularization. Koster A; Rosendahl U; von Hodenberg E; Ennker J Ann Thorac Surg; 2010 Jul; 90(1):276-7. PubMed ID: 20609794 [TBL] [Abstract][Full Text] [Related]
16. Anticoagulation for cardiopulmonary bypass: is a replacement for heparin on the horizon? Warkentin TE J Thorac Cardiovasc Surg; 2006 Mar; 131(3):515-6. PubMed ID: 16515897 [No Abstract] [Full Text] [Related]
17. Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF study. Smedira NG; Dyke CM; Koster A; Jurmann M; Bhatia DS; Hu T; McCarthy HL; Lincoff AM; Spiess BD; Aronson S J Thorac Cardiovasc Surg; 2006 Mar; 131(3):686-92. PubMed ID: 16515924 [TBL] [Abstract][Full Text] [Related]
18. Bivalirudin: alternative anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia. Grubb KJ; Salehi P; Chedrawy EG Recent Pat Cardiovasc Drug Discov; 2010 Jan; 5(1):20-4. PubMed ID: 19903167 [TBL] [Abstract][Full Text] [Related]
19. An assay to monitor bivalirudin levels on cardiopulmonary bypass. Salemi A; Agrawal YP; Fontes MA Ann Thorac Surg; 2011 Jul; 92(1):332-4. PubMed ID: 21718867 [TBL] [Abstract][Full Text] [Related]
20. Cardiopulmonary bypass for complex cardiac surgery using bivalirudin anticoagulation in a patient with heparin antibodies. Huebler M; Koster A; Buz S; Boettcher W; Hetzer R; Kuppe H; Dyke CM J Card Surg; 2006; 21(3):286-8. PubMed ID: 16684064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]